This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Biopeptides Corporation, The State University of New York, Brookhaven Science Associates, Lcc. Active years: 2006-2024.
Location History:
- Setauket, NY (US) (2006 - 2009)
- East Setauket, NY (US) (2011 - 2024)
Company Filing History:
6 out of 6 
5 out of 2,044 
2 out of 351 
Years Active: 2006-2024
Title: Innovations by Raymond Dattwyler in Lyme Disease Diagnosis
Introduction
Raymond Dattwyler is a notable inventor based in East Setauket, NY (US), recognized for his significant contributions to the field of medical diagnostics, particularly concerning Lyme disease. With a total of six patents to his name, Dattwyler has developed innovative methods that enhance the detection and treatment of this complex illness.
Latest Patents
Dattwyler's latest patents focus on compositions and methods for diagnosing Lyme disease and predicting the elimination of Lyme disease spirochetes after treatment. These patents provide advanced techniques for detecting, diagnosing, and prognosing Lyme disease. One method involves using synthetic peptides that contain T-cell epitope regions derived from proteins expressed at various stages of Lyme disease. This method allows for the indirect detection of Lyme disease-specific activated T-cells by measuring the production of immune response indicators, such as interferon-Y, in response to these peptides. Additionally, his patents disclose methods for predicting the elimination of Lyme disease spirochetes in patients who have undergone treatment, by analyzing whole blood samples for specific T-cell responses.
Career Highlights
Throughout his career, Dattwyler has worked with prominent companies in the biotechnology sector, including Biopeptides Corporation and Qiagen Sciences, LLC. His experience in these organizations has contributed to his expertise in developing diagnostic methods that are both innovative and practical.
Collaborations
Dattwyler has collaborated with esteemed colleagues in his field, including Paul M Arnaboldi and Maria Gomes-Solecki. These partnerships have furthered his research and development efforts, leading to advancements in Lyme disease diagnostics.
Conclusion
Raymond Dattwyler's work in the field of Lyme disease diagnosis exemplifies the impact of innovative thinking in medical science. His patents and collaborations highlight the importance of continued research and development in improving health outcomes for patients affected by this disease.